Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of three clinical trials

Paller, A.S., Siegfried, E.C., Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (6 more authors) (2025) Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of three clinical trials. Journal of the American Academy of Dermatology. ISSN 0190-9622

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.
Keywords: atopic dermatitis; biomarkers; dupilumab; erythrodermic; pediatric eczema
Dates:
  • Accepted: 22 May 2025
  • Published (online): 27 May 2025
  • Published: 27 May 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 10 Jun 2025 10:06
Last Modified: 10 Jun 2025 10:06
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.jaad.2025.05.1422
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)